Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort. Read more about Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort.
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance). Read more about Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having. Read more about Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having.
Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone. Read more about Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone.
Groundwater constituents and the incidence of kidney cancer. Read more about Groundwater constituents and the incidence of kidney cancer.
Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Read more about Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial. Read more about Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma. Read more about Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma.
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study. Read more about The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
Lower leukemia burden maximizes the impact of blinatumomab therapy. Read more about Lower leukemia burden maximizes the impact of blinatumomab therapy.
